Policy / Pricing

Biotech leaders pitch Pazdur as next FDA chief

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

pharminent May 14, 2026 (Last updated: May 14, 2026)

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

Related Stories

UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged

EU agrees plan to tackle essential medicine shortages

340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar)

You May Have Missed

Biogen takes tau Alzheimer’s therapy to Phase 3 despite mid-stage fail, prompting cautious optimism

With new data, Regenxbio to seek FDA approval of Duchenne gene therapy

Biotech leaders pitch Pazdur as next FDA chief

Degron adds $40M to series A, supporting immunology plans for molecular glue platform